These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 39205873)
1. Advanced tumor organoid bioprinting strategy for oncology research. Cui X; Jiao J; Yang L; Wang Y; Jiang W; Yu T; Li M; Zhang H; Chao B; Wang Z; Wu M Mater Today Bio; 2024 Oct; 28():101198. PubMed ID: 39205873 [TBL] [Abstract][Full Text] [Related]
2. Organoid bioinks: construction and application. Wang F; Song P; Wang J; Wang S; Liu Y; Bai L; Su J Biofabrication; 2024 May; 16(3):. PubMed ID: 38697093 [TBL] [Abstract][Full Text] [Related]
3. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation. Dai R; Chen W; Chen Y; Jin J; Zhang S; Zhang C; Liu J Biofabrication; 2024 Jun; 16(3):. PubMed ID: 38810618 [TBL] [Abstract][Full Text] [Related]
4. Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids. Clark CC; Yoo KM; Sivakumar H; Strumpf K; Laxton AW; Tatter SB; Strowd RE; Skardal A Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36332268 [TBL] [Abstract][Full Text] [Related]
5. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications. Maharjan S; Ma C; Singh B; Kang H; Orive G; Yao J; Shrike Zhang Y Adv Drug Deliv Rev; 2024 May; 208():115237. PubMed ID: 38447931 [TBL] [Abstract][Full Text] [Related]
6. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research - State-of-the-art. Frankowski J; KurzÄ…tkowska M; Sobczak M; Piotrowska U Int J Pharm; 2023 Sep; 644():123313. PubMed ID: 37579828 [TBL] [Abstract][Full Text] [Related]
7. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs. Skardal A; Devarasetty M; Kang HW; Mead I; Bishop C; Shupe T; Lee SJ; Jackson J; Yoo J; Soker S; Atala A Acta Biomater; 2015 Oct; 25():24-34. PubMed ID: 26210285 [TBL] [Abstract][Full Text] [Related]
8. Converging bioprinting and organoids to better recapitulate the tumor microenvironment. Wang X; Luo Y; Ma Y; Wang P; Yao R Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145 [TBL] [Abstract][Full Text] [Related]
9. Developments and Opportunities for 3D Bioprinted Organoids. Ren Y; Yang X; Ma Z; Sun X; Zhang Y; Li W; Yang H; Qiang L; Yang Z; Liu Y; Deng C; Zhou L; Wang T; Lin J; Li T; Wu T; Wang J Int J Bioprint; 2021; 7(3):364. PubMed ID: 34286150 [TBL] [Abstract][Full Text] [Related]
10. A review of biomacromolecule-based 3D bioprinting strategies for structure-function integrated repair of skin tissues. Liu H; Xing F; Yu P; Zhe M; Duan X; Liu M; Xiang Z; Ritz U Int J Biol Macromol; 2024 May; 268(Pt 2):131623. PubMed ID: 38642687 [TBL] [Abstract][Full Text] [Related]
11. Bioinks for 3D bioprinting: an overview. Gungor-Ozkerim PS; Inci I; Zhang YS; Khademhosseini A; Dokmeci MR Biomater Sci; 2018 May; 6(5):915-946. PubMed ID: 29492503 [TBL] [Abstract][Full Text] [Related]
12. Advancements in Research on Constructing Physiological and Pathological Liver Models and Their Applications Utilizing Bioprinting Technology. Ming Z; Tang X; Liu J; Ruan B Molecules; 2023 Apr; 28(9):. PubMed ID: 37175094 [TBL] [Abstract][Full Text] [Related]
13. Application of three-dimensional (3D) bioprinting in anti-cancer therapy. Wu BX; Wu Z; Hou YY; Fang ZX; Deng Y; Wu HT; Liu J Heliyon; 2023 Oct; 9(10):e20475. PubMed ID: 37800075 [TBL] [Abstract][Full Text] [Related]
14. 3D bioprinting for organ and organoid models and disease modeling. Juraski AC; Sharma S; Sparanese S; da Silva VA; Wong J; Laksman Z; Flannigan R; Rohani L; Willerth SM Expert Opin Drug Discov; 2023; 18(9):1043-1059. PubMed ID: 37431937 [TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Bioprinting of Organoids: Past, Present, and Prospective. Cabral M; Cheng K; Zhu D Tissue Eng Part A; 2024 Jun; 30(11-12):314-321. PubMed ID: 38205663 [TBL] [Abstract][Full Text] [Related]
16. Nanoengineered Osteoinductive Bioink for 3D Bioprinting Bone Tissue. Chimene D; Miller L; Cross LM; Jaiswal MK; Singh I; Gaharwar AK ACS Appl Mater Interfaces; 2020 Apr; 12(14):15976-15988. PubMed ID: 32091189 [TBL] [Abstract][Full Text] [Related]
17. Drug screening at single-organoid resolution via bioprinting and interferometry. Tebon PJ; Wang B; Markowitz AL; Davarifar A; Tsai BL; Krawczuk P; Gonzalez AE; Sartini S; Murray GF; Nguyen HTL; Tavanaie N; Nguyen TL; Boutros PC; Teitell MA; Soragni A Nat Commun; 2023 Jun; 14(1):3168. PubMed ID: 37280220 [TBL] [Abstract][Full Text] [Related]
18. Candidate Bioinks for Extrusion 3D Bioprinting-A Systematic Review of the Literature. Tarassoli SP; Jessop ZM; Jovic T; Hawkins K; Whitaker IS Front Bioeng Biotechnol; 2021; 9():616753. PubMed ID: 34722473 [No Abstract] [Full Text] [Related]
19. 3D bioprinting complex models of cancer. Sharma R; Restan Perez M; da Silva VA; Thomsen J; Bhardwaj L; Andrade TAM; Alhussan A; Willerth SM Biomater Sci; 2023 May; 11(10):3414-3430. PubMed ID: 37000528 [TBL] [Abstract][Full Text] [Related]
20. Peptide-dendrimer-reinforced bioinks for 3D bioprinting of heterogeneous and biomimetic in vitro models. Zhou K; Ding R; Tao X; Cui Y; Yang J; Mao H; Gu Z Acta Biomater; 2023 Oct; 169():243-255. PubMed ID: 37572980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]